All charges against ex-Vungle CEO Zain Jaffer have been dismissed at the request of San Mateo DA, who said prescribed drugs from multiple doctors were at fault
Last fall we reported that tech entrepreneur Zain Jaffer was arrested on a variety of awful charges, including sexual assault of his own child.
Context & Ripple Effects
When Vungle's board put Zain Jaffer on indefinite leave within days of his October 2017 arrest on attempted murder and child assault charges, the move read as standard crisis governance: sever the executive, let the courts run. Nine months later the San Mateo DA has asked for — and won — dismissal of every charge, attributing the episode to prescribed drugs Jaffer was taking from multiple doctors rather than criminal intent.
That reversal matters beyond one founder: it reopens the question of whether immediate leave-and-condemn responses to pre-trial charges serve companies well when the underlying cause turns out to be medical, and it lands in a corpus where prescription practices are themselves becoming prosecutable — see the 2024 arrests of telehealth firm Done Global's founder and head doctor over an alleged Adderall-prescribing scheme.
First-order effects
- Jaffer exits the case with no convictions on any charge, restoring his legal standing roughly nine months after the arrest that cost him the Vungle CEO role.
- Vungle's board faces the awkward aftermath of having removed its CEO on charges the DA now says were medically caused — with no stated path back to the role he left.
Second-order effects
- Boards handling founder crises get a cautionary data point: acting on arrest headlines before adjudication can mean permanently losing a leader over conduct a prosecutor later attributes to prescriptions, not crimes.
- The DA's multi-doctor prescribing explanation shifts attention toward prescribers themselves, foreshadowing the scrutiny that later produced criminal charges against Done Global's founder and head doctor.
Third-order effects
- If the pattern holds, accountability in these cases migrates upstream from the patient-executive to the prescribing system — doctors and telehealth platforms face legal exposure while individuals like Jaffer see charges dropped.
- Tech governance may drift toward reversible, staged responses to executive arrests rather than immediate permanent removal, since early charges do not reliably predict outcomes.
The trend: Criminal cases against tech founders are increasingly resolving around medical causation, moving legal and reputational risk from the individual toward the prescribing system behind their treatment.